Valiant Laboratories Limited IPO is set to launch on 27 September, 2023. The company initiated its business operations in the year 1980. It is a pharmaceutical ingredient manufacturing company and is focused on manufacturing paracetamol. The company’s manufacturing facility is located in Maharashtra. It is spread in 2000 sq mtrs and has an annual capacity of 9000 MT. It imports PARA AMINO PHENOL which is the raw material for manufacturing paracetamol. This is done though China and Cambodia for cheaper purchase cost. The company currently employees 86 people.
Valiant Laboratories Limited IPO DETAILS
Valiant Laboratories Limited IPO is set to launch on 27 September, 2023. The subscription timeline extends till 3 October, 2023. The size for the IPO is 152.46 Crore Rs. Shares issued through fresh issue mode are worth 152.46 Crore Rs. No shares are Issued through offer for sale mode. The lot size is 105 shares and the price is 133 to 140 Rs per share. The company is going to get listed at both NSE and BSE. The face value per share is Rs.10 and this is a Book Built issue. The registrar for the company is Link Intime India Private Limited.
IPO OPENING DATE | 27 September, 2023 |
CLOSING DATE FOR IPO | 3 October, 2023 |
ISSUE TYPE | Book Built Issue |
Face Value per share | 10 Rs. per share |
IPO price band | 133 Rs. to 140 Rs. per share |
LOT SIZE | 105 shares |
MINIMUM ORDER QUANTITY | 105 shares |
ISSUE SIZE | 152.46 Crore Rs. |
OFFER FOR SALE | No shares are issued through offer for sale mode |
FRESH ISSUE | 152.46 Crore Rs. |
LISTING AT | NSE, BSE |
LISTING DATE | 9 October, 2023 |
IPO OPENING DATE | 27 September, 2023 |
CLOSING DATE FOR IPO | 3 October, 2023 |
IPO ALLOTMENT DATE | 5 October, 2023 |
REFUNDS | 6 October, 2023 |
DEMAT A/C CREDITED ON | 6 October, 2023 |
IPO LISTING DATE | 9 October, 2023 |
Valiant Laboratories Limited IPO begins for subscription from 27 September 2023. The IPO subscription would continue till 3 October, 2023. The allotment status for the shareholders who applied would come on 5 October, 2023. The refunds for the ones who did not get allotment would be initiated on 6 October, 2023. The DEMAT accounts of shareholders would be credited on 6 October, 2023. The listing of the company would be completed on 9 October, 2023.
The lead managers are :
The minimum lot size for the company is decided at 105 shares. This holding accounts to 14700 Rs.. The maximum lot size is decided at 1365 shares. This amounts to 191100 Rs.. Hence the company’s final holdings would be set as :
Shares | Amount | |
Minimum | 105 shares | 14700 Rs. |
Maximum | 1365 shares | 191100 Rs. |
Particularly (in Crore Rs.) | 2020-21 | 2021-22 | 2022-23 |
ASSETS | 106 | 181 | 212 |
Revenue | 183 | 293 | 338 |
PAT | 30 | 27 | 29 |
Valiant Laboratories Limited had an asset base of 106 Crore Rs in the year 2021. This increased to 181 Crore Rs in the year 2022 and 212 Crore Rs in the year 2023. The revenue of the company is 183 Crore Rs for the year 2021. This increased to a mega 293 Crore Rs in the next year. The revenue for the year 2023 was 338 Crore Rs. The company has been low on the profit achievement. The profit of the company was 30 Crore Rs in 2021. This decreased to 27 Crore Rs in 2022. Further on the profit increased to 29 Crore Rs in 2023 as compared to 2022. However the profit of the year 2023 is still lower than the 30 Crore achieved in 2021.
It is very easy to apply for an IPO now if you have a DEMAT account with Zerodha. Follow the steps below for the same :
Now, applying for an IPO online is possible with most of the Discount and online brokers.
Effwa Infra & Research Limited IPO is set to launch on 5 July, 2024. The…
Ambey Laboratories Limited IPO is set to launch on 4 July, 2024. The company initiated…
Bansal Wire Industries Limited IPO is set to launch on 3 July, 2024. The company…
Emcure Pharmaceuticals Limited IPO is set to launch on 3 July, 2024. The company initiated…
Nephro Care India Limited IPO is set to launch on 28 June, 2024. The company…
Diensten Tech Limited IPO is set to launch on 26 June, 2024. The company initiated…
This website uses cookies.